Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
| HCPC | J2793 |
| Short Description | Rilonacept injection |
| Long Description | Injection, rilonacept, 1 mg |
| Pricing indicator | 51 |
| Coverage code | D |
| ASC payment group code | |
| BETOS2 code | O1E |
| Action code | N |
| Type of service | 1 |
| Effective date | 2019-01-01 |
| Date Added | 2010-01-01 |
Drug Details
-
Rilonacept injection is used to treat cryopyrin-associated periodic syndromes (CAPS; inherited conditions in which the body attacks its own tissues causing inflammation, joint and muscle pain, rash or other skin lesions, fever and chills, eye redness or pain, and fatigue), including familial cold autoinflammatory syndrome (FCAS), and Muckle-Wells syndrome (MWS) in adults and children 12 years of age or older. Rilonacept injection is also used to treat deficiency of interleukin-1 receptor antagonist (DIRA; a disorder in which the body attacks its own tissues causing inflammation and damages bones, nervous system, skin, lungs, liver, and joints) in adults and children who weigh at least 22 pounds (10 kg). Rilonacept injection is also used to treat recurrent pericarditis (swelling of the sac around the heart) and also to prevent the return of pericarditis in adults and children 12 years of age or older. Rilonacept is in a class of medications called interleukin antagonists. It works by blocking the activity of interleukin, a substance in the body that causes inflammation.